- Poster presentation
- Open Access
Diagnostic algorithm for Primary Ciliary Dyskinesia: recommendations of the French National Centre for Rare Respiratory Diseases
© Blanchon et al; licensee BioMed Central Ltd. 2012
- Published: 16 November 2012
- Nitric Oxide
- Cystic Fibrosis
- Otitis Medium
Primary Ciliary Dyskinesia (PCD) is a inherited disorder characterized by abnormal ciliary structure/function, responsible for impaired muco-ciliary transport and infertility. The diagnosis is often delayed for several years though PCD is a rare (~1/20,000) and heterogeneous disease. We elaborated recommendations aiming at improving the quality and efficacy of PCD diagnosis.
A multicentric working group, created in 2009 within the French National Centre for Rare Respiratory Diseases, elaborated precise and practical algorithm for PCD diagnosis, based on their experience and the recent literature. It includes adults and paediatric physicians, biologists and technicians involved in PCD, dealing since many years with the difficulties to confirm this diagnosis.
PCD diagnosis should be clinically suggested by general features (recurrent upper and lower airways infections early in life, laterality defects, infertility, familial consanguinity or PCD history), concurrent with ENT (nasal polyposis, chronic rhinosinusitis, otitis media) and pulmonary symptoms (chronic bronchitis, bronchiectasis). After exclusion of overlapping pathologies (cystic fibrosis, immunodeficiency), a ciliary dysfunction (assessed by nasal nitric oxide and/or ciliary beat frequency analysis) is a necessary criteria to select patients requiring ultrastructural analysis by electron microscopy, our gold standard for diagnosis confirmation. High-speed-video-microscopy could be helpful in case of discrepancy between clinical features, functional and structural ciliary analysis.
The French National Centre reminds the features of PCD, and describes a step by step algorithm for diagnosis. Based on these recommendations, a more accurate approach in patients suspected for PCD will improve the quality and efficacy of investigations; reducing the delay to diagnosis.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.